Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.

Bernstein lowered the firm’s price target on Johnson & Johnson to $160 from $177 and keeps a Market Perform rating on the shares as part of ...

"I'd say there's a 70% chance Mike Johnson is going to be speaker ... because that's just the way the swamp works," ...

Kentucky, wrote on X that a different speaker of the House of Representatives could win the vote if Louisiana Republican Mike ...

WASHINGTON — Rep. Mike Johnson, R-La., narrowly won reelection Friday as House speaker on a first ballot, overcoming ...

Speaker Mike Johnson (R-La.) on Thursday expressed confidence about his chances ahead of the House’s Speaker vote on Friday. ...

President-elect Donald Trump on Monday endorsed Speaker Mike Johnson to continue leading the House, just days before the ...

House Republicans have said for weeks that Donald Trump would have the final say on whether Johnson keeps the gavel or is replaced.

A man in Maine is suing pharmeceutical giant Johnson & Johnson for $25 million over the death of his wife, claiming that use of its “dangerous and defective” talcum powder caused her death.

Are you wondering which testosterone booster is best for men? Perhaps you'd like to know which testosterone boosters could help guys achieve a better quality of life. People have scoured the ...

SpaceX said it would be the 17th flight for the Falcon 9 first-stage booster supporting this mission, which previously launched Crew-5, GPS III Space Vehicle 06, Inmarsat I6-F2, CRS-28 ...